Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis

NCT07750574 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelofibrosis
Myelofibrosis Due to and Following Polycythemia Vera
Myelofibrosis Transformation in Essential Thrombocythemia
Myelofibrosis With High Molecular Risk Mutations
Myelofibrosis With Myeloid Metaplasia
Myelofibrosis, Post ET
Myelofibrosis, Post PV
Myelofibrosis, Primary
Myelofibrosis; Anemia
Myelofibrosis，MF
Myelofibrosis (PMF)
Myeloid Metaplasia

Interventions

DRUG: Flonoltinib Maleate orally
DRUG: Flonoltinib Maleate orally
DRUG: Flonoltinib Maleate orally

Sponsor

Chengdu Zenitar Biomedical Technology Co., Ltd